OF SPECIAL INTEREST
Buprenorphine transdermal system has REMS
New drugs and dosage forms
FDA advisers recommend new controls on rosiglitazone use
FDA works toward product naming, packaging guidance
Appointment
Leapfrog Group wants hospitals to monitor, not just implement, CPOE systems
Pharmacist involvement in fall prevention
Role of the pharmacist in a presurgical clinic designed to optimize outcomes after elective total joint arthroplasty
A dream deferred
Liraglutide
Evaluating equivalence and noninferiority trials
Commonly prescribed medications and potential false-positive urine drug screens
Angioedema after nonsteroidal antiinflammatory drug initiation in a patient stable on an angiotensin-converting-enzyme inhibitor
Unique case of presumed lisinopril-induced hepatotoxicity
Outcomes associated with transdermal nicotine replacement therapy in a neurosurgery intensive care unit
Medication therapy management and condition care services in a community-based employer setting
Educational program for pharmacists at a multifacility academic medical center
Inaugural address of the President-elect
Management of medication use in Scotland
2010 Report of the Executive Vice President and Chief Executive Officer
2010 Report of the ASHP Treasurer
Professional policies approved by the 2010 ASHP House of Delegates
ASHP Board of Directors, 2010–2011
ASHP Honorary Membership